首页 | 本学科首页   官方微博 | 高级检索  
检索        

前列地尔对糖尿病肾病蛋白尿的影响
引用本文:王海燕.前列地尔对糖尿病肾病蛋白尿的影响[J].医学综述,2011,17(18):2843-2844.
作者姓名:王海燕
作者单位:齐鲁石化医院集团中心医院肾内科,山东,淄博,255400
摘    要:目的评价前列地尔对早期糖尿病肾病患者尿蛋白的影响。方法选择确诊为早期糖尿病肾病患者,随机分为前列地尔组(A组,47例)和对照组(B组,40例)。观察12周,检测各组患者治疗前后尿蛋白等指标。结果 A组治疗后空腹血糖、餐后2 h血糖、血肌酐与对照组比较,差异无统计学意义(P>0.05),但A组治疗后尿蛋白排泄率明显下降,与B组比较,差异有统计学意义(P<0.01)。结论前列地尔可明显降低早期糖尿病肾病患者尿蛋白,从而更大程度地保护肾脏,延缓肾功能恶化。

关 键 词:前列地尔  糖尿病肾病  尿蛋白

Alprotadil Influence on Uric Protein due to Diabetic Nephropathy
WANG Hai-yan.Alprotadil Influence on Uric Protein due to Diabetic Nephropathy[J].Medical Recapitulate,2011,17(18):2843-2844.
Authors:WANG Hai-yan
Institution:WANG Hai-yan.(Department of Nephrology,Central Hospital of Qilu Petro-chemical Hospital,Zibo 255400,China)
Abstract:Objective To evaluate the influence of Alprotadil on uric protein of patients suffering from early-staged diabetic nephropathy.Methods Patients who have been firmly diagnosed as early-staged diabetic nephropathy were chosen and divided into two groups,namely,Alprostadil group(group A) and contrast group(group B).The observation lasted for twelve weeks,and indexes such as uric protein were checked.Results There was no significant difference(P>0.05)between group A and group B in fasting glucose,2h postprandia...
Keywords:Alprostadil  Diabetic nephropathy  Uric protein  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号